Who owns ELIEM THERAPEUTICS INC?
- Ticker: CLYM
- CUSIP Number: 28658r106
Tip: Access positions for across all investors
Analyze quarterly positions in Eliem Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Eliem Therapeutics stock
Who bought or sold ELIEM THERAPEUTICS INC this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| RA Capital Management | 31M | $63M | 0% | Sep 2025 |
|
| Vanguard Group | 1.3M | $2.6M | -1% | Sep 2025 |
|
| Affinity Asset Advisors | 1.3M | $2.6M | -13% | Sep 2025 |
|
| Kynam Capital Management | 1.0M | $2.1M | 0% | Sep 2025 |
|
| Tang Capital Management | 1.0M | $2.0M | 0% | Sep 2025 |
|
| BlackRock | 736k | $1.5M | -16% | Sep 2025 |
|
| Peapod Lane Capital | 562k | $1.1M | 1% | Sep 2025 |
|
| Cantor Fitzgerald, L. P. | 547k | $1.1M | -78% | Sep 2025 |
|
| Renaissance Technologies | 537k | $1.1M | 8% | Sep 2025 |
|
| Deep Track Capital | 510k | $1.0M | -51% | Sep 2025 |
|
| Alyeska Investment Group | 485k | $976k | 0% | Sep 2025 |
|
| Millennium Management | 472k | $948k | -2% | Sep 2025 |
|
| Nan Fung Trinity | 464k | $932k | 0% | Sep 2025 |
|
| Sphera Funds Management | 435k | $874k | 107% | Sep 2025 |
|
| UBS Group | 405k | $815k | 6% | Sep 2025 |
|
| Geode Capital Management | 312k | $627k | 0% | Sep 2025 |
|
| Marshall Wace | 230k | $462k | 526% | Sep 2025 |
|
| Shay Capital | 150k | $302k | -64% | Sep 2025 |
|
| Susquehanna International | 143k | $286k | 128% | Sep 2025 |
|
| Diadema Partners | 137k | $274k | 100% | Sep 2025 |
|
| ADAR1 Capital Management | 134k | $268k | 12% | Sep 2025 |
|
| Northern Trust | 125k | $252k | -11% | Sep 2025 |
|
| Two Sigma Investments | 113k | $227k | -37% | Sep 2025 |
|
| Bridgeway Capital Management | 109k | $220k | -19% | Sep 2025 |
|
| State Street Corporation | 103k | $207k | 0% | Sep 2025 |
|
| Morgan Stanley | 100k | $123k | 100% | Jun 2025 |
|
| TD Asset Management | 89k | $180k | 0% | Sep 2025 |
|
| Two Sigma Advisers | 81k | $163k | -15% | Sep 2025 |
|
| Jane Street | 80k | $160k | -46% | Sep 2025 |
|
| Goldman Sachs Group | 74k | $148k | -39% | Sep 2025 |
|
| LPL Financial | 61k | $123k | 100% | Sep 2025 |
|
| Citizens Financial Group | 46k | $93k | 100% | Sep 2025 |
|
| Springbok Capital Management | 41k | $82k | 100% | Sep 2025 |
|
| Manufacturers Life Insurance Company | 39k | $78k | 0% | Sep 2025 |
|
| Cubist Systematic Strategies | 39k | $78k | -38% | Sep 2025 |
|
| Qube Research & Technologies | 37k | $74k | 7% | Sep 2025 |
|
| XTX Topco | 29k | $59k | 100% | Sep 2025 |
|
| Barclays | 25k | $50k | -16% | Sep 2025 |
|
| Advisor Group Holdings | 23k | $45k | 7561% | Sep 2025 |
|
| Jpmorgan Chase & Co | 22k | $44k | -93% | Sep 2025 |
|
| Susquehanna Portfolio Strategies | 18k | $37k | 100% | Sep 2025 |
|
| Squarepoint Ops | 18k | $36k | -10% | Sep 2025 |
|
| Walleye Trading Advisors | 15k | $30k | 100% | Sep 2025 |
|
| JustInvest | 15k | $29k | 100% | Sep 2025 |
|
| Tower Research Capital | 13k | $27k | -6% | Sep 2025 |
|
| Hsbc Holdings | 12k | $24k | -10% | Sep 2025 |
|
| China Universal Asset Management | 12k | $24k | -12% | Sep 2025 |
|
| Point72 Asia | 11k | $22k | -22% | Sep 2025 |
|
| Chicago Partners Investment | 10k | $22k | -20% | Sep 2025 |
|
| FMR | 7.1k | $14k | -6% | Sep 2025 |
|
| Federated Investors | 4.4k | $8.9k | 100% | Sep 2025 |
|
| Mirae Asset Global Investments | 2.6k | $5.3k | 0% | Sep 2025 |
|
| Harbour Investments | 2.0k | $4.0k | 100% | Sep 2025 |
|
| Bnp Paribas Arbitrage, Snc | 1.9k | $3.7k | -76% | Sep 2025 |
|
| Gf Fund Management | 1.5k | $2.9k | -10% | Sep 2025 |
|
| Royal Bank of Canada | 691.00 | $1.1k | -76% | Sep 2025 |
|
| NISA Investment Advisors | 573.00 | $1.2k | 0% | Sep 2025 |
|
| EverSource Wealth Advisors | 224.00 | $449.993600 | 339% | Sep 2025 |
|
| CWM | 107.00 | $0 | -96% | Sep 2025 |
|
| SRS Capital Advisors | 53.00 | $106.000000 | 100% | Sep 2025 |
|
| Advisory Services Network | 32.00 | $64.000000 | 100% | Sep 2025 |
|
| SBI Securities | 13.00 | $26.000000 | 8% | Sep 2025 |
|
| Deutsche Bank Aktiengesellschaft | 1.00 | $2.000000 | -100% | Sep 2025 |
|
Who sold out of Eliem Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Jun 2025 | 138k | $172k |
| Y-Intercept | Jun 2025 | 128k | $159k |
| Stonepine Capital Management | Jun 2025 | 116k | $144k |
| AQR Capital Management | Jun 2025 | 29k | $36k |
| Jain Global | Jun 2025 | 26k | $32k |
| Hrt Financial | Jun 2025 | 19k | $22k |
| SG Americas Securities | Jun 2025 | 14k | $17k |
| Point72 | Jun 2025 | 421.00 | $521.997900 |
| Wells Fargo & Company | Jun 2025 | 244.00 | $302.999200 |
| Raymond James Financial | Jun 2025 | 200.00 | $248.000000 |
| True Wealth Design | Jun 2025 | 19.00 | $24.000800 |
| Hartland & Co | Jun 2025 | 11.00 | $13.999700 |